Polymorphisms in the methotrexate transport pathway

Koppen, 2010, Folate related gene polymorphisms and susceptibility to develop childhood acute lymphoblastic leukaemia., Br J Haematol, 148, 3, 10.1111/j.1365-2141.2009.07898.x

Johnston, 2010, Childhood cancer survival: a report from the United Kingdom Childhood Cancer Study., Cancer Epidemiol, 34, 659, 10.1016/j.canep.2010.06.020

Pui, 2008, Acute lymphoblastic leukemia., Lancet, 371, 1030, 10.1016/S0140-6736(08)60457-2

Imanishi, 2007, Genetic polymorphisms associated with adverse events and elimination of methotrexate in childhood acute lymphoblastic leukemia and malignant lymphoma., J Hum Genet, 52, 166, 10.1007/s10038-006-0096-z

Ongaro, 2009, Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival., Haematologica, 94, 1391, 10.3324/haematol.2009.008326

Kishi, 2007, Ancestry and pharmacogenetics of antileukemic drug toxicity., Blood, 109, 4151, 10.1182/blood-2006-10-054528

Shimasaki, 2008, Influence of MTHFR and RFC1 polymorphisms on toxicities during maintenance chemotherapy for childhood acute lymphoblastic leukemia or lymphoma., J Pediatr Hematol Oncol, 30, 347, 10.1097/MPH.0b013e318165b25d

Karathanasis, 2011, The role of the methylenetetrahydrofolate reductase 677 and 1298 polymorphisms in Cretan children with acute lymphoblastic leukemia., Genet Test Mol Biomarkers, 15, 5, 10.1089/gtmb.2010.0083

Huang, 2008, Polymorphisms in folate related genes: association with side effects of high-dose methotrexate in childhood acute lymphoblastic leukemia., Leukemia, 22, 1798, 10.1038/leu.2008.66

Tantawy, 2010, Methylene tetrahydrofolate reductase gene polymorphism in Egyptian children with acute lymphoblastic leukemia., Blood Coagul Fibrinolysis, 21, 28, 10.1097/MBC.0b013e32833135e9

Kantar, 2009, Methylenetetrahydrofolate reductase C677T and A1298C gene polymorphisms and therapy related toxicity in children treated for acute lymphoblastic leukemia and non-Hodgkin lymphoma., Leuk Lymphoma, 50, 912, 10.1080/10428190902893819

Krajinovic, 2005, Combining several polymorphisms of thymidylate synthase gene for pharmacogenetic analysis., Pharmacogenomics J, 5, 374, 10.1038/sj.tpj.6500332

Liu, 2011, Effects of methylenetetrahydrofolate reductase gene polymorphisms on toxicities during consolidation therapy in pediatric acute lymphoblastic leukemia in a Chinese population., Leuk Lymphoma, 52, 1030, 10.3109/10428194.2011.563883

Faganel Kotnik, 2011, Association of genetic polymorphism in the folate metabolic pathway with methotrexate pharmacokinetics and toxicity in childhood acute lymphoblastic leukaemia and malignant lymphoma., Eur J Clin Pharmacol, 67, 993, 10.1007/s00228-011-1046-z

Erdilyi, 2008, Synergistic interaction of ABCB1 and ABCG2 polymorphisms predicts the prevalence of toxic encephalopathy during anticancer chemotherapy., Pharmacogenomics J, 8, 321, 10.1038/sj.tpj.6500480

Lopez-Lopez, 2011, Polymorphisms of the SLCO1B1 gene predict methotrexate-related toxicity in childhood acute lymphoblastic leukemia., Pediatr Blood Cancer, 57, 612, 10.1002/pbc.23074

Trevino, 2009, Germline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effects., J Clin Oncol, 27, 5972, 10.1200/JCO.2008.20.4156

Benjamini, 1995, Controlling the false discovery rate: a practical and powerful approach to multiple testing., J R Stat Soc Ser, 57, 289, 10.1111/j.2517-6161.1995.tb02031.x

Gabriel, 2002, The structure of haplotype blocks in the human genome., Science, 296, 2225, 10.1126/science.1069424

Samuelsson, 2011, Frequent somatic demethylation of RAPGEF1C3G intronic sequences in gastrointestinal and gynecological cancer., Int J Oncol, 38, 1575

Low, 2009, Association study of genetic polymorphism in ABCC4 with cyclophosphamide-induced adverse drug reactions in breast cancer patients., J Hum Genet, 54, 564, 10.1038/jhg.2009.79

Nicoletti, 2012, Genomewide pharmacogenetics of bisphosphonate-induced osteonecrosis of the jaw: the role of RBMS3., Oncologist, 17, 279, 10.1634/theoncologist.2011-0202

Krishnamurthy, 2008, Transporter-mediated protection against thiopurine-induced hematopoietic toxicity., Cancer Res, 68, 4983, 10.1158/0008-5472.CAN-07-6790

Ansari, 2009, Polymorphisms in multidrug resistance-associated protein gene 4 is associated with outcome in childhood acute lymphoblastic leukemia., Blood, 114, 1383, 10.1182/blood-2008-11-191098

Abla, 2008, The human multidrug resistance protein 4 (MRP4, ABCC4): functional analysis of a highly polymorphic gene., J Pharmacol Exp Ther, 325, 859, 10.1124/jpet.108.136523

Kruh, 2007, Physiological and pharmacological functions of Mrp2, Mrp3 and Mrp4 as determined from recent studies on gene-disrupted mice., Cancer Metastasis Rev, 26, 5, 10.1007/s10555-007-9039-1

Lee, 2000, Analysis of the MRP4 drug resistance profile in transfected NIH3T3 cells., J Natl Cancer Inst, 92, 1934, 10.1093/jnci/92.23.1934

Chen, 2002, Analysis of methotrexate and folate transport by multidrug resistance protein 4 (ABCC4): MRP4 is a component of the methotrexate efflux system., Cancer Res, 62, 3144

Stamp, 2010, Polymorphisms within the folate pathway predict folate concentrations but are not associated with disease activity in rheumatoid arthritis patients on methotrexate., Pharmacogenet Genomics, 20, 367, 10.1097/FPC.0b013e3283398a71

Rau, 2006, High-dose methotrexate in pediatric acute lymphoblastic leukemia: impact of ABCC2 polymorphisms on plasma concentrations., Clin Pharmacol Ther, 80, 468, 10.1016/j.clpt.2006.08.012

Lubomirov, 2010, ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir., Pharmacogenet Genomics, 20, 217, 10.1097/FPC.0b013e328336eee4

Ohmann, 2010, Genetic polymorphisms influence mycophenolate mofetil-related adverse events in pediatric heart transplant patients., J Heart Lung Transplant, 29, 509, 10.1016/j.healun.2009.11.602

Rodriguez-Novoa, 2009, Predictors of kidney tubular dysfunction in HIV-infected patients treated with tenofovir: a pharmacogenetic study., Clin Infect Dis, 48, e108, 10.1086/598507

Choi, 2007, MRP2 haplotypes confer differential susceptibility to toxic liver injury., Pharmacogenet Genomics, 17, 403, 10.1097/01.fpc.0000236337.41799.b3

Daly, 2007, Genetic susceptibility to diclofenac-induced hepatotoxicity: contribution of UGT2B7, CYP2C8, and ABCC2 genotypes., Gastroenterology, 132, 272, 10.1053/j.gastro.2006.11.023

Han, 2009, Integrated pharmacogenetic prediction of irinotecan pharmacokinetics and toxicity in patients with advanced non-small cell lung cancer., Lung Cancer, 63, 115, 10.1016/j.lungcan.2007.12.003

Sookoian, 2008, Association of the multidrug-resistance-associated protein gene (ABCC2) variants with intrahepatic cholestasis of pregnancy., J Hepatol, 48, 125, 10.1016/j.jhep.2007.08.015

Han, 2011, Association of ABCC2 polymorphisms with platinum-based chemotherapy response and severe toxicity in non-small cell lung cancer patients., Lung Cancer, 72, 238, 10.1016/j.lungcan.2010.09.001

Nies, 2007, The apical conjugate efflux pump ABCC2 (MRP2)., Pflugers Arch, 453, 643, 10.1007/s00424-006-0109-y

Gerk, 2002, Regulation of expression of the multidrug resistance-associated protein 2 (MRP2) and its role in drug disposition., J Pharmacol Exp Ther, 302, 407, 10.1124/jpet.102.035014